neuroprotective agents (Shanghai Key Laboratory of New Drug Design)

N/A

Report date: 2025/01/26 17:30:06
NME

Base Information

Drug Nameneuroprotective agents (Shanghai Key Laboratory of New Drug Design)
Drug Alias Namenitric oxide production inhibitors (Shanghai Key Laboratory of New Drug Design)sarsasapogenin-AA13AA-13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide synthase inhibitors
TargetsNitric oxide synthase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEast China University Of Science And Technology
China Registration ClassN/A

Develop Information

Active CompaniesEast China University Of Science And Technology
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A